7.21

6.00% -0.46

After Hours: 7.58 0.37 +5.13%

Lixte Biotechnology Holdings Inc (LIXT)

Overview News Price History Financials Discussions Forecast Stock Split

Lixte Biotechnology Holdings Inc stock is traded at $7.21, with a volume of 614.08K. It is down -6.00% in the last 24 hours and up +3.00% over the past month. Lixte Biotechnology Holdings Inc is a clinical-stage biopharmaceutical and proton cancer therapy company focused on identifying new targets for cancer drug development and developing and commercializing cancer therapies. The company's drug product pipeline is focused on inhibitors of protein phosphatase 2A, which is used to enhance cytotoxic agents, radiation, immune checkpoint blockers and other cancer therapies. Its product is LB-100 for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer. The company operates in a single reportable segment, which consists of the development of cancer treatments.

Previous Close:

$7.67

Open:

$7.95

24h Volume:

614.08K

Relative Volume:

2.86

Market Cap:

$125.36M

Revenue:

Net Income/Loss:

$-7.29M

P/E Ratio:

-6.4186

EPS:

-1.1233

Net Cash Flow:

$-7.00M

1W Performance:

-10.32%

1M Performance:

+3.00%

6M Performance:

+102.53%

1Y Performance:

+154.77%

1-Day Range:

$7.00

$7.99

1-Week Range:

$7.00

$8.3773

52-Week Range:

$2.02

$8.3773

Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile

Name

Lixte Biotechnology Holdings Inc

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

310 203 2902

Address

433 PLAZA REAL, BOCA RATON

Employee

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

LIXT's Discussions on Twitter

Compare LIXT vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LIXT Lixte Biotechnology Holdings Inc	7.21	129.01M	0	-7.29M	-7.00M	-1.1233
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Lixte Biotechnology Holdings Inc Stock (LIXT) Latest News

Jul 01, 2026

LIXTLixte Biotechnology Holdings Inc Latest SEC Filings - Finviz

Jul 01, 2026

Jun 29, 2026

Enterprise value to revenue forward of Lixte Biotechnology Holdings, Inc. – NASDAQ:LIXT - TradingView

Jun 29, 2026

Enterprise value to revenue forward of Lixte Biotechnology Holdings, Inc. – MUN:8640 - TradingView

Jun 29, 2026

Lixte Biotechnology Holdings, Inc.(NasdaqCM: LIXT) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Lixte Biotechnology Holdings, Inc.(NasdaqCM:LIXT) added to Russell 3000E Growth Benchmark - marketscreener.com

Jun 28, 2026

Lixte Biotechnology Holdings, Inc.(NasdaqCM: LIXT) added to Russell Microcap Index - marketscreener.com

Jun 28, 2026

Jun 26, 2026

LIXT Joins Russell Microcap Index Amid Annual Reconstitution - GuruFocus

Jun 26, 2026

LIXTE Biotechnology Joins Russell Microcap Index, Boosting Visibility Among Institutional Investors - citybuzz -

Jun 26, 2026

LIXTE joins Russell Microcap Index - MSN

Jun 26, 2026

LIXTE added to Russell Microcap Index effective today By Investing.com - Investing.com Australia

Jun 26, 2026

LIXTE added to Russell Microcap Index effective today - Investing.com

Jun 26, 2026

Lixte Biotechnology Friday sector view, small-cap biotech shares stay speculative - AD HOC NEWS

Jun 26, 2026

LIXTE Joins Russell Microcap Index - The Manila Times

Jun 26, 2026

LIXTE Biotechnology Holdings, Inc. Added to Russell Microcap Index - Quiver Quantitative

Jun 26, 2026

LIXTE Biotechnology Holdings joins Russell Microcap Index - scanx.trade

Jun 26, 2026

Jun 25, 2026

Price to sales forward of Lixte Biotechnology Holdings, Inc. – NASDAQ:LIXT - TradingView

Jun 25, 2026

Jun 24, 2026